Poster Submission Deadline: 15 September 2023
All abstracts will be reviewed by the Scientific Advisory Board and applicants will
be notified of the result in due course.
Successful applicants will be provided with all necessary information.
Abstract Content:
- Written in English
- Written in the third person
- Include title, name(s) and affiliation(s) of the authors
- Between 100 - 200 words
- Suitable for direct publication in the proceedings pack and on the website
- Related to the subject of the conference
Agenda Topics- Cancer Immunotherapy: CAR-T, NK, Checkpoint Inhibitors
- Cell & Gene Therapies: Technologies and Clinical Status
- Clinical Trials and Commercialization of Cell Therapies
- Extracellular Vesicles (EVs): Potential for Regenerative Medicine
- Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
- Stem Cells for Cellular Therapy
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility
of the content of the abstract and we assume that all co-authors are aware of this
content. Please note that your biography, summary and abstract may be used on this
website and conference materials.
|
